antirheumatic


Also found in: Dictionary.

antirheumatic

 [an″te-, an″ti-roo-mat´ik]
counteracting rheumatism and rheumatoid disease.

an·ti·rheu·mat·ic

(an'tē-rū-mat'ik), Although the digraph rh occurring at the beginning of a syllable in a word of Greek origin is ordinarily changed to rrh when a prefix or other lexical element is placed before it, the r is not doubled in this word.
1. Denoting an agent that suppresses manifestations of rheumatic disease; usually applied to antiinflammatory agents or agents that are capable of delaying progression of the basic disease process in inflammatory arthritis.
2. An agent possessing such properties (for example, gold compounds).

antirheumatic

/an·ti·rheu·mat·ic/ (-roo-mat´ik)
1. relieving or preventing rheumatism.
2. an agent that so acts.

antirheumatic

[-roo͡mat′ik]
Etymology: Gk, anti + rheumatismos, that which flows
pertaining to the relief of symptoms of any painful or immobilizing disorder of the musculoskeletal system.

antirheumatic

Any treatment for, or prophylaxis against, any form of rheumatism.
References in periodicals archive ?
Those not taking disease-modifying antirheumatic medications (DMARDs), however, had a normal immune response, which suggests that it's the immunomodulating medications, not the disease itself, that are affecting antibody levels, Roger Hesselstrand, MD, of Lund (Sweden) University and his colleagues reported online in Rheumatology.
The second study by the group looked to see if concomitant use of what are called conventional synthetic disease-modifying antirheumatic drugs (csDMARDs, such as methotrexate and chloroquine) or corticosteroids contribute to the increased risk of shingles linked to tofacitinib.
Kineret is a recombinant protein drug indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients 18 years of age or older who have failed 1 or more disease-modifying antirheumatic drugs (DMARDs).
One hundred thirty-nine patients with rheumatoid arthritis for less than 12 months who had not previously received disease-modifying antirheumatic drugs (DMARDs) were randomly assigned to receive, in double-blind fashion, in a 2:1 ratio, a high dose (5.
Thousands of tons of plastic bottle caps are expected to be collected by May 1next year through a programme titled 'I can`t get enough of them', organised by the ministry of education and the Cyprus Antirheumatic Association.
Headquarters: Tokyo, President: Masuji Sugata, "Toyama Chemical") announced today that they have received notification from Japan's Ministry of Health, Labour and Welfare (MHLW) to the effect that the "all-case surveillance" special drug use-results survey condition required for approval of the antirheumatic agent iguratimod (Eisai brand name: Careram, Toyama Chemical brand name: KOLBET) has been lifted.
USPRwire, Wed Aug 12 2015] Non-steroidal anti-inflammatory drug (NSAID) has a totally different chemical structure from steroids which have a similar anti-inflammatory antirheumatic action.
LISBON -- Advanced age appears to trump disease activity or antirheumatic drug treatment as the driving force behind miscarriage in women with rheumatoid arthritis.
These patients were compared with 82,258 controls who did not have any of these inflammatory conditions and who were not taking any disease-modifying antirheumatic drugs (DMARDs).
The terrible side effects of the non-steroidal antiinflammatory drugs(NSAID) used to treat Rheumatoid arthritis (RA) include heartburn, stomach problems, ulcers and even bleeding, while the more effective disease modifying antirheumatic drugs (DMARD) can cause high blood pressure, cataracts, weight gain, sleep problems, muscle loss, bruising and thinning of the bones (osteoporosis).
Methotrexate (MTX) is the anchor treatment for rheumatoid arthritis and similar inflammatory conditions and has been very thoroughly studied in many different patient populations, as monotherapy and in combination with various other disease modifying antirheumatic drugs and biologic agents.
There soon may be a new oral disease-modifying antirheumatic drug in town, the first in more than 10 years to be approved for the treatment of rheumatoid arthritis.